RAD54L2 and renal cell carcinoma: Rad54l2 expression in RCC, was significantly decreased in male, age over 60 years old, T2&T3&T4 stages, pathologic SII&SIII&SIV stages as well as histologic G3&G4 grades, and cox regression analysis proved that Rad54l2 expression was a risk factor for OS, DSS and PFI in univariate analysis.